The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.

Three new studies shed light on some common questions about atrial fibrillation: whether your morning coffee matters, whether ...

Routine liver function tests (LFTs) typically comprise alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, ...

At the 2025 International Kidney Cancer Symposium, Dr. Michael Staehler, of the University of Munich, highlighted the ...

With Thanksgiving just days away, many are preparing to fill their plates with all the fixings, but local health experts want ...

There’s a new physician making the rounds, and his name is Dr. Google. He has a terrible bedside manner, an opinion on ...

In a society where the mirror often reflects not just our faces but the relentless march of time, few stories capture the ...

Metformin treatment in type 1 diabetes lowers insulin dosage but does not improve insulin resistance, highlighting its ...

A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease: exercise.

The surprising findings could improve how doctors manage type 1 diabetes and ease the significant burden that people with the condition face when using insulin alone. In their published paper in ...

HealthDay News — The benefits of metformin outweigh the risks for young people with bipolar spectrum disorder who have overweight or obesity and are treated with second-generation antipsychotics, ...

In a piece by Dan Ross, he looks at the first metformin study which shows the drug has “prolonged detection time” ...